Nanofibrous Encapsulation Device for Stem Cell Therapy Retrieval
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current encapsulation devices for stem cell-based therapies, such as those for type 1 diabetes, face challenges with immunosuppression risks, teratoma formation, and the inability to ensure complete graft retrieval, while also dealing with mechanical weaknesses and foreign body reactions that can lead to cell escape and reduced long-term functionality.
Innovation Solution
An implantable therapeutic delivery device featuring a hydrogel core with therapeutic agents surrounded by a durable, porous nanofibrous substrate made from biocompatible thermoplastic silicone-polycarbonate-urethane (TSPU) that provides immunological protection and allows for facile mass transfer, enabling long-term safety and functionality, and can be retrieved using laparoscopic procedures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If alginate microcapsule-based encapsulation systems are used, then cell viability and immunoprotective properties are maintained, but complete graft retrieval is impossible and long-term reliability is reduced
Solution Approach 1:
The device is segmented into two functional parts: a biodegradable alginate microcapsule containing the cells and a permanent polyethylene terephthalate (PET) mesh scaffold for structural support and retrieval. This segmentation allows the microcapsule to be replaced over time while the durable scaffold remains for future retrieval operations.
Solution Approach 2:
The device combines two materials with complementary properties: alginate provides biocompatibility and immunoprotective properties, while PET mesh provides mechanical strength, porosity control, and long-term durability. This composite structure resolves the contradiction between biocompatibility and long-term reliability.
2Reliability
If alginate hydrogels are used for encapsulation, then cell containment and immunoprotection are achieved, but mechanical strength is insufficient leading to swelling and breakage
Solution Approach 1:
The device combines two materials with complementary properties: alginate provides biocompatibility and immunoprotective properties, while PET mesh provides mechanical strength, porosity control, and long-term durability. This composite structure resolves the contradiction between biocompatibility and long-term reliability.
Solution Approach 2:
The PET mesh acts as a flexible yet strong outer shell that provides mechanical support to the alginate hydrogel core, preventing swelling and breakage while maintaining the encapsulation function. The mesh structure is both mechanically robust and biocompatible.
3Reliability
If small pore size membranes are used in encapsulation devices, then cell escape is prevented, but mass transfer is diminished reducing long-term function
Solution Approach 1:
The device utilizes a porous PET mesh structure with controlled pore sizes that allow sufficient mass transfer while preventing cell escape. The porosity is optimized to balance these two requirements, enabling nutrient and waste exchange while maintaining cell containment.
Solution Approach 2:
The device creates different functional zones: the alginate microcapsule provides a protected environment for cells with its own porosity, while the outer PET mesh provides structural support and additional porosity control. Each layer has locally optimized properties for its specific function.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device maintains continuous containment of encapsulated cells for extended periods, restores normoglycemia in diabetic models, and demonstrates scalability and retrievability, offering a balanced approach between safety and functionality for stem cell-based therapies.
Implementation Method 1
an elongated nanofibrous substrate having proximal and distal ends, said nanofiber substrate having an interior nanofiber wall defining an internal space
Implementation Method 2
a hydrogel core; one or more therapeutic agents suspended within the hydrogel core
Data Source
AI summary
The present disclosure is directed to an implantable therapeutic delivery device. This device comprises a hydrogel core; one or more therapeutic agents suspended within the hydrogel core; and an elongated nanofibrous substrate having proximal and distal ends, said nanofiber substrate having an interior nanofiber wall defining an internal space that extends longitudinally between the proximal and distal ends of the substrate, wherein the hydrogel core comprising the one or more therapeutic agents is positioned within the internal space. The disclosure is also directed to methods of delivering a therapeutic agent to a subject in need thereof that involves implanting the device described herein.